Pharmacy

The FINANCIAL -- AstraZeneca and MedImmune, the Company’s global biologics research and development arm, on April 24 announced that they have entered into a collaboration to accelerate and broaden the development of Innate Pharma SA’s proprietary anti-NKG2A antibody, IPH2201, including in combination with MEDI4736, an anti-PD-L1 immune checkpoint inhibitor developed by ...

More Articles ...

More Articles ...

The FINANCIAL -- Novo Nordisk on April 22 announced that Saxenda (liraglutide 3 mg) is now available in the United States (US). Saxenda is the first glucagon-like peptide-1 (GLP-1) receptor agonist ...

The FINANCIAL -- Bayer HealthCare and University Medical Center Hamburg-Eppendorf (UKE) are the main coordinators of the newly founded international consortium CANCER-ID to develop and validate novel ...

Videos

Watch the video